| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecda217e338758c93b75a09b1b75159d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c64bb1a500acce0764ca85021d3b3fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8058bc8343a043b79d67da726daaed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf55665312ffde9f1788271eb8ea3af3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b949f1f2a7c12cbecc68a975ce9c2a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5732f3dd1a84a6da7f938db854d86889 |
| publicationDate |
2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160111909-A |
| titleOfInvention |
Reticulocyte growth factor, and preparation method and application thereof |
| abstract |
The present invention relates to reticulocyte growth factor (RGF), a process for its preparation and its use. The present invention separates and purifies the factor from α 1 -antitrypsin (derived from human plasma), which factor is a fragment in the precursor of the α 1 -antitrypsin molecule, which promotes the production of reticulocytes in the mouse It confirms that it has a powerful function. The RGF of the present invention can be prepared as a drug for the treatment of severe anemia. |
| priorityDate |
2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |